# BioVeda Capital

BioVeda Capital is a Private Equity based in Singapore, Singapore.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Singapore, Singapore
- **Region:** Asia
- **Address:** Singapore
- **Founded:** 2000
- **Assets under management:** Undisclosed
- **Website:** biovedacapital.com
- **LinkedIn:** https://www.linkedin.com/company/bioveda-capital

## Regulatory record

- **Reports private funds:** No

## About

BioVeda Capital is a Singapore-based firm that invests in healthcare companies with market positions, proprietary technologies, and scientific and management talent. The firm has made 24 investments, including a Series B investment in CXA Group on February 07, 2017. BioVeda Capital has 8 portfolio exits, with Clarus Therapeutics being the most recent on September 09, 2021.

## Sectors

- Healthcare Services
- Digital Health
- Biotech

## Questions

### Which geographies does BioVeda cover?

The firm invests across Asia, with a primary focus on Southeast Asia, India, and North Asian markets. Its Singapore headquarters provides proximity to regional regulatory bodies, clinical-trial infrastructure, and the Biopolis biomedical research cluster. No additional offices beyond Singapore are publicly documented.

### Does BioVeda Capital invest through funds or only direct deals?

BioVeda operates through direct equity investments in healthcare companies rather than acting as a fund-of-funds allocator. The firm takes structured minority positions and participates in venture and growth-stage rounds. Fund structure details — whether the firm raises discretionary funds or deploys on a deal-by-deal basis — are not available in public disclosures.

### Who manages investment decisions at BioVeda Capital?

BioVeda has not publicly disclosed the identities of its managing principals, investment committee members, or portfolio managers. No named executives appear in press coverage, regulatory filings, or the firm's limited digital footprint as of mid-2026. The absence of disclosed leadership is notable for an institutional allocator conducting operational due diligence.

## Related profiles

- [Bioshore Capital Partners](https://altss.com/profile/bioshore-capital-partners)
- [Birdflight Investments](https://altss.com/profile/birdflight-investments)

---

Updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/bioveda-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology